Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing alternate dosing of spironolactone versus finerenone to evaluate safety in patients with elevated potassium related to heart failure a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finerenone (finerenone)
  • Spironolactone (spironolactone)

Snippet

Sponsor: Hospital de Messejana Dr. Carlos Alberto Studart Gomes | Conditions: Heart Failure, Diabetic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING